Today, the State Drug Administration recently approved the launch of two “pathogen metagenomic detection reagents”, including a “global new” detection reagent for acute respiratory illness and a “new Chinese” detection reagent for bloodstream infections. The respiratory pathogen nucleic acid detection kit is the world's first respiratory pathogen detection kit based on metagene detection technology. It is mainly used for auxiliary diagnosis of lung infections; the nucleic acid detection kit for bloodstream infections is the first metagenomic detection kit for bloodstream infections in China. What is a “pathogen metagenomic detection reagent”? Pathogen metagenomic sequencing technology tests not one or several specific bacteria or viruses, but the nucleic acid of all microorganisms in the sample. It does not rely on microbial culture of the pathogen, but uses high-throughput sequencing technology to detect the nucleic acid of all pathogens in the sample. In other words, it detects information on various pathogens such as bacteria, fungi, atypical pathogens, viruses, and parasites that cause infections in patients at once. [Microphone] How is it different from traditional reagents? Traditional pathogen microbiological testing techniques require doctors to predict pathogenic microorganisms and then select microbial detection techniques based on the results. However, pathogen metagenomic testing technology can test the nucleic acid of all pathogenic microorganisms in a specimen at once, speeding up the detection of pathogenic microorganisms. How can patients benefit? Experts said that the approval of the new test reagent made up for the current lack of clinical diagnosis of difficult infectious diseases around the world and provided a timely and effective auxiliary diagnosis basis for clinical treatment.

Today, the State Drug Administration recently approved the launch of two “pathogen metagenomic detection reagents”, including a “global new” detection reagent for acute respiratory illness and a “new Chinese” detection reagent for bloodstream infections. The respiratory pathogen nucleic acid detection kit is the world's first respiratory pathogen detection kit based on metagene detection technology. It is mainly used for auxiliary diagnosis of lung infections; the nucleic acid detection kit for bloodstream infections is the first metagenomic detection kit for bloodstream infections in China. What is a “pathogen metagenomic detection reagent”? Pathogen metagenomic sequencing technology tests not one or several specific bacteria or viruses, but the nucleic acid of all microorganisms in the sample. It does not rely on microbial culture of the pathogen, but uses high-throughput sequencing technology to detect the nucleic acid of all pathogens in the sample. In other words, it detects information on various pathogens such as bacteria, fungi, atypical pathogens, viruses, and parasites that cause infections in patients at once. [Microphone] How is it different from traditional reagents? Traditional pathogen microbiological testing techniques require doctors to predict pathogenic microorganisms and then select microbial detection techniques based on the results. However, pathogen metagenomic testing technology can test the nucleic acid of all pathogenic microorganisms in a specimen at once, speeding up the detection of pathogenic microorganisms. How can patients benefit? Experts said that the approval of the new test reagent made up for the current lack of clinical diagnosis of difficult infectious diseases around the world and provided a timely and effective auxiliary diagnosis basis for clinical treatment.